- Home
- INDB vs VKTX Comparison
INDB vs VKTX Comparison
Compare INDB & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDB
- VKTX
- Stock Information
- Founded
- INDB 1907
- VKTX 2012
- Country
- INDB United States
- VKTX United States
- Employees
- INDB N/A
- VKTX N/A
- Industry
- INDB Major Banks
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- INDB Finance
- VKTX Health Care
- Exchange
- INDB Nasdaq
- VKTX Nasdaq
- Market Cap
- INDB 3.2B
- VKTX 3.5B
- IPO Year
- INDB N/A
- VKTX 2015
- Fundamental
- Price
- INDB $70.94
- VKTX $26.00
- Analyst Decision
- INDB Buy
- VKTX Strong Buy
- Analyst Count
- INDB 3
- VKTX 13
- Target Price
- INDB $71.00
- VKTX $86.92
- AVG Volume (30 Days)
- INDB 360.1K
- VKTX 9.0M
- Earning Date
- INDB 10-16-2025
- VKTX 07-23-2025
- Dividend Yield
- INDB 3.33%
- VKTX N/A
- EPS Growth
- INDB N/A
- VKTX N/A
- EPS
- INDB 4.43
- VKTX N/A
- Revenue
- INDB $662,753,000.00
- VKTX N/A
- Revenue This Year
- INDB $30.64
- VKTX N/A
- Revenue Next Year
- INDB $22.87
- VKTX $338.60
- P/E Ratio
- INDB $15.98
- VKTX N/A
- Revenue Growth
- INDB N/A
- VKTX N/A
- 52 Week Low
- INDB $52.15
- VKTX $18.92
- 52 Week High
- INDB $77.23
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- INDB 67.09
- VKTX 36.68
- Support Level
- INDB $66.23
- VKTX $23.21
- Resistance Level
- INDB $67.64
- VKTX $26.74
- Average True Range (ATR)
- INDB 1.84
- VKTX 2.19
- MACD
- INDB 0.44
- VKTX -1.68
- Stochastic Oscillator
- INDB 99.49
- VKTX 14.67
About INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.